United Kingdom· GB-APID-41396911000001103
Tecvayli 153mg/1.7ml solution for injection vials
A teclistamab product containing teclistamab, registered in United Kingdom by Janssen-Cilag Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Teclistamab is registered in 14 of 19 countries.
Countries holding a registration under ATC L01FX24 (teclistamab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Teclistamab · ATC L01FX24
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Teclistamab
- Manufacturer
- Janssen-Cilag Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01FX24
- ATC class
- Teclistamab
- Defined daily dose
- 15 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin05099467003025
- gtin5099467003025
- gtin05012674904220
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Teclistamab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTECVAYLIJanssen-Cilag International NV
- CanadaTECVAYLIJANSSEN INC
- SwitzerlandTecvayli 153 mg/1.7 ml, InjektionslösungJanssen-Cilag AG
- CzechiaTECVAYLIJanssen-Cilag International N.V., Beerse
- SpainTECVAYLI 10 MG/ML SOLUCION INYECTABLEJanssen-Cilag International N.V
- FranceTECVAYLI 10 mg/mL, solution injectableJANSSEN CILAG INTERNATIONAL NV
- United StatesTECVAYLIJanssen Biotech, Inc.
- BelgiumTecvayli 10 mg/mlJanssen-Cilag International
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tecvayli
- Liechtenstein · Tecvayli
- Norway · Tecvayli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32ff0791-3253-41b3-bd41-d1e7d9164364 GET /v1/drugs/32ff0791-3253-41b3-bd41-d1e7d9164364?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "41396911000001103",
"desc": "Tecvayli 153mg/1.7ml solution for injection vials (Janssen-Cilag Ltd)",
"form": "Solution for injection",
"vpid": "41462711000001105",
"source": "dmd",
"vtm_id": "41457211000001109",
"strength": "90 mg",
"substance": "Teclistamab",
"ingredient": "Teclistamab",
"supplier_code": "2422501000001106"
}See everything about teclistamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.